Headquarters
100 5TH AVE FL 3, WALTHAM, MA 02451-8727, US
WALTHAM, MA, US
APL SALES I LLC
From the company
Apellis Pharmaceuticals is a biopharmaceutical company that develops therapies targeting C3 to treat diseases driven by excessive activation of the complement cascade, including in hematology, ophthalmology, and nephrology. Its focus areas include geographic atrophy and rare disease. Apellis has been acquired by Biogen.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.